Trillium Therapeutics Inc. (TRIL.TO) (TSE:TRIL) and (PREV) (CNSX:PREV) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, profitability, earnings, institutional ownership and risk.
Valuation & Earnings
This table compares Trillium Therapeutics Inc. (TRIL.TO) and (PREV)'s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Trillium Therapeutics Inc. (TRIL.TO) | C$115,000.00 | 12,969.57 | $-291,552,555.00 | C($2.90) | -5.12 |
(PREV) | N/A | N/A | N/A | N/A | N/A |
(PREV) has lower revenue, but higher earnings than Trillium Therapeutics Inc. (TRIL.TO).
Analyst Recommendations
This is a summary of current ratings and recommmendations for Trillium Therapeutics Inc. (TRIL.TO) and (PREV), as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Trillium Therapeutics Inc. (TRIL.TO) | 0 | 0 | 0 | 0 | N/A |
(PREV) | 0 | 0 | 0 | 0 | N/A |
Trillium Therapeutics Inc. (TRIL.TO) presently has a consensus price target of C$25.00, indicating a potential upside of 68.80%.
Profitability
This table compares Trillium Therapeutics Inc. (TRIL.TO) and (PREV)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Trillium Therapeutics Inc. (TRIL.TO) | N/A | N/A | N/A |
(PREV) | N/A | N/A | N/A |
Summary
Trillium Therapeutics Inc. (TRIL.TO) beats (PREV) on 1 of the 1 factors compared between the two stocks.